Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Alexion Pharmaceuticals, Inc.    ALXN

Delayed Quote. Delayed  - 12/02 10:00:00 pm
122.96 USD   +0.78%
11/29DJU.S. Stocks Edge Higher
11/29 ALEXION PHARMAC : to Present at the Citi 2016 Global Healthcare Conf..
11/29DJU.S. Stocks Edge Higher
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/28/2016 11/29/2016 11/30/2016 12/01/2016 12/02/2016 Date
119.38(c) 125.59(c) 122.59(c) 122.01(c) 122.96(c) Last
1 901 678 3 298 599 1 636 720 1 675 717 1 247 037 Volume
+0.46% +5.20% -2.39% -0.47% +0.78% Change
More quotes
Financials ($)
Sales 2016 3 092 M
EBIT 2016 1 319 M
Net income 2016 527 M
Debt 2016 1 801 M
Yield 2016 -
Sales 2017 3 570 M
EBIT 2017 1 614 M
Net income 2017 849 M
Debt 2017 1 368 M
Yield 2017 -
P/E ratio 2016 51,14
P/E ratio 2017 33,03
EV / Sales2016 9,50x
EV / Sales2017 8,11x
Capitalization 27 574 M
More Financials
Company
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the innovation, development and commercialization of life-transforming therapeutic products.Its products include soliris, strensiq and kanuma.The company... 
Sector
Pharmaceuticals
Calendar
12/05 | 03:00amPresentation
More about the company
Surperformance© ratings of Alexion Pharmaceuticals, I
Trading Rating : Investor Rating :
More Ratings
Latest news on ALEXION PHARMACEUTICALS, I
03:49a ALEXION PHARMACEUTICALS, INC. : Khang & Khang LLP Announces Securities Class Act..
12/01 ALEXION PHARMACEUTICALS, INC. : SHAREHOLDER NOTICE: Lundin Law PC Announces Secu..
12/01 ROBBINS ARROYO LLP : Alexion Pharmaceuticals, Inc. ALXN Misled Shareholders Acco..
11/30 ALEXION PHARMACEUTICALS, INC. : Khang & Khang LLP Announces Securities Class Act..
11/29DJU.S. Stocks Edge Higher
11/29 ALEXION PHARMACEUTICALS, INC. : INVESTOR NOTICE: Lundin Law PC Announces Securit..
11/29 ALEXION PHARMACEUTICALS, INC. : SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossma..
11/29 ALEXION PHARMACEUTICALS : to Present at the Citi 2016 Global Healthcare Conferen..
11/29DJU.S. Stocks Edge Higher
11/28 ALEXION PHARMACEUTICALS, INC. : Khang & Khang LLP Announces Securities Class Act..
More news
Sector news : Biopharmaceuticals
01:25aDJJOHNSON & JOHNSON : Boosts Actelion Bid -Bloomberg
12/02 Pharma execs weigh in on possible changes under Trump
12/02DJJOHNSON & JOHNSON : Jury Orders Johnson & Johnson to Pay More Than $1 Billion in..
12/01DJValeant Deal Talks Collapse Over Price -- WSJ
12/01DJCSL : Eyes Biggest Undertaking Yet in Heart Therapy Trial
More sector news : Biopharmaceuticals
News from SeekingAlpha
11/29 Barclays likes Alexion, sees 25% upside
11/23 Competitive Results May Affect Omeros Corporation
11/23 Biotech And Big Pharma Are Acting As If Hillary Clinton Won The Election
11/18 Gilead has multiple prospects if it decides to pull trigger on acquisition
11/09 Alexion -1.3% as it delays 10-Q on internal sales probe
Advertisement
Chart ALEXION PHARMACEUTICALS, I
Duration : Period :
Alexion Pharmaceuticals, I Technical Analysis Chart | ALXN | US0153511094 | 4-Traders
Full-screen chart
Technical analysis trends ALEXION PHARMACEU...
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 172 $
Spread / Average Target 40%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
David L. Hallal Chief Executive Officer & Director
Leonard Bell Chairman
Julie O'Neill Executive Vice President-Global Operations
Vikas Sinha Chief Financial Officer & Executive Vice President
Martin MacKay Executive VP, Global Head-Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ALEXION PHARMACEUTICAL..-35.54%27 574
BIOGEN INC-3.45%64 661
CSL LIMITED-5.78%33 156
BIOMARIN PHARMACEUTICA..-18.26%14 139
GRIFOLS SA-15.08%12 072
CHONGQING ZHIFEI BIOLO..--.--%4 303
More Results